VHCP Management as of Dec. 31, 2012
Portfolio Holdings for VHCP Management
VHCP Management holds 14 positions in its portfolio as reported in the December 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 26.9 | $27M | 2.4M | 11.08 | |
| Neurocrine Biosciences (NBIX) | 16.8 | $17M | 2.2M | 7.48 | |
| Tesaro | 11.3 | $11M | 657k | 16.95 | |
| GTx | 9.0 | $8.9M | 2.1M | 4.20 | |
| Anacor Pharmaceuticals In | 8.5 | $8.4M | 1.6M | 5.20 | |
| Keryx Biopharmaceuticals | 7.0 | $6.9M | 2.6M | 2.62 | |
| Repros Therapeutics | 5.8 | $5.7M | 364k | 15.75 | |
| Biodel | 3.0 | $3.0M | 1.3M | 2.35 | |
| Threshold Pharmaceuticals | 2.9 | $2.9M | 684k | 4.21 | |
| Hyperion Therapeutics | 2.9 | $2.8M | 250k | 11.28 | |
| Alexza Pharmaceuticals | 2.5 | $2.5M | 500k | 4.95 | |
| Chelsea Therapeutics International | 1.9 | $1.9M | 2.5M | 0.76 | |
| Anthera Pharmaceuticals | 0.9 | $891k | 1.4M | 0.62 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $558k | 393k | 1.42 |
